Skip to main content

Healthcare Global Enterprises Ltd

Stage 3 · Topping · week 1⚠ 2→3 today

As of 16 Oct 2026, Healthcare Global Enterprises is in Stage 3 — topping, where an uptrend loses steam, in its first week (since 16 Oct 2026). It closed at ₹588, 24.2% below its 52-week high and below its 200-day average, which is falling. In Health Care, 40.6% of stocks are in Stage 2.

HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. More about the company

₹588.2
-0.41% today
₹8,782 Cr · Mid cap
Market Neutral — FadingHealth Care 40.6% in Stage 2-7.4 pts / 20dHospitals & Diagnostic Centres 19.4%-19.4 pts

Pro read

Pro

Our read

Topping — the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is HCG early, or has it already run? Pro answers that for every NSE stock, after every close.

Loading price chart…
vs 52W High
-24.2%
₹521.8 lo₹776.3 hi
24.2% below 52W high — weakening from peak
Stock is rolling over from its 52W high. Stage 3 distribution — new longs are high risk here.
Stage Maturity
Week 1
1w13w26w
Week 1 — early distribution
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
-6.7%
200 DMA: ₹630.4 · sloping down
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
0.86x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution — institutions are exiting. A clear warning to avoid new longs.
Trend Health
↓
MA20 rolling over · -5.5% vs MA50 -0.6%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-12.7%
3M
-10.3%
6M
+3.6%
YTD
-15.3%
1Y
-11.7%
Sector
Health Care
↓ Peaking
Stage 2%
40.6%
20d Δ
-7.4pp
1M return
-3.8%
3M return
-1.0%
Sector Stage-2 % · last 20 days
Sector has 67 Stage 2 leaders. See Health Care Stage 2 →
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
19.4%
20d Δ
-19.4pp
1M return
-10.4%
3M return
-12.2%
Industry Stage-2 % · last 20 days
Industry has 5 Stage 2 leaders. See Hospitals & Diagnostic Centres Stage 2 →
Stage Cycle Timeline2023-07-20 → 2026-10-16
S2 27w
S2 56w
S2 22w
2023-07-202026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 27w → S3 4w → S2 2w → S3 8w → S1 1w → S4 3w → S1 1w → S2 56w → S3 4w → S2 22w → S3 6w → S4 12w → S1 10w → S2 12w → S3 1w current
Total tracked: 168 weeks across 15 stage runs.
Scan Membership
Prop Scan
Latest: 2026-09-29
Pullback Hunter
Latest: 2026-08-21
Breakout Watch
Latest: 2026-07-24
48 appearances in last 60 days. First seen: 2024-02-26.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding — staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-16S32→3
Wk 1 · Vol 0.86x
2026-10-15S2
Wk 12 · Vol 1.20x
2026-10-14S2
Wk 12 · Vol 0.58x
2026-10-13S2
Wk 12 · Vol 1.87x
2026-10-12S2
Wk 11 · Vol 2.57x
2026-10-09S2
Wk 11 · Vol 4.66x
2026-10-08S2
Wk 11 · Vol 0.45x
2026-10-07S2
Wk 11 · Vol 0.26x
2026-10-06S2
Wk 11 · Vol 0.76x
2026-10-05S2
Wk 10 · Vol 0.26x
2026-10-01S2
Wk 10 · Vol 0.70x
2026-09-30S2
Wk 10 · Vol 1.28x
Sector Peers — Stage 2All →
BAFNAPH
wk 19 · 0.0% from hi
8.6
KILITCH
wk 3 · -11.6% from hi
8.4
LAURUSLABS
wk 26 · -0.4% from hi
7.8
KOPRAN
wk 20 · -6.8% from hi
7.4
ZIMLAB
wk 23 · -5.2% from hi
6.9
Moving averages & range
50 DMA
₹687
200 DMA
₹630.4
52W High
₹776.3
52W Low
₹521.8
5D Low
₹579.4
Resistance levels (recent highs)
20d High
₹713.1
60d High
₹745.3
120d High
₹745.3
250d High
₹776.3
Next resistance
+21.2%
to 20d High
P/E (TTM)
673.4
Forward 46.1
Earnings Growth (YoY)
-71.2%
Revenue +11.5%
ROE
+1.9%
Profit margin +0.5%
About this companyHealth Care· Hospitals & Diagnostic Centres

HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and theranostics, chemotherapy, robotic surgery, actinium and lutetium therapy, immunotherapy, psycho-oncology, targeted drug therapy, bone marrow transplant, pediatric oncology, organ preservation and reconstructive surgery, endocrine therapy, and liver transplant; and post care services comprising patient care, psychological support, nutrition and dietetics, multidisciplinary rehabilitation, and genetic counselling. It also provides cancer screening, interventional radiology, MRI, nephrology, clinical trial, hormone therapy, hematology, CAR T cell, translational and nuclear medicine, oncodermatology, anaesthesiology, paediatric and gynaecologic oncology, orthopaedic oncology, uro-oncology, infectious diseases, gastrointestinal and thoracic oncology, breast surgical oncology, clinical pharmacology, and pain and palliative services. In addition, the company operates multi-specialty hospitals under the HCG brand that offers inpatient and outpatient treatments with specialties in cardiology, neurology, orthopaedics, gastroenterology, urology, internal medicine and pulmonary, and critical care. Further, it provides oncology diagnostics services, including biomarker and translational research, and clinical research services under the Triesta Sciences brand; and fertility treatment services, including reproductive medicine, assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. HealthCare Global Enterprises Limited was founded in 1989 and is headquartered in Bengaluru, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.